SCHEMBL16628867

SCHEMBL16628867

Cc1ccc(-c2cc(C(=O)NC(C)c3nc(C)no3)nc(-c3ccc(C)cc3)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.53
TP53 P04637 1/20 0.53
RIPK1 Q13546 1/20 0.46
ADORA3 P0DMS8 3/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ADORA1 P30542 1/20 0.41
ACACB O00763 6/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
THRB P10828 1/20 0.41
KCNT1 Q5JUK3 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2261759 1.00 SMN1; SMN2 (0.53) SMN1; SMN2TP53RIPK1ADORA3KMT2A
SCHEMBL22892041 0.96 TP53 (0.52) SMN1; SMN2TP53RIPK1KMT2AMEN1
SCHEMBL13365619 0.77 MAPT (0.54) SMN1; SMN2TP53ADORA3NPC1RAB9A
SCHEMBL3109357 0.71 SMN1; SMN2 (0.65) SMN1; SMN2TP53KMT2AMEN1NPC1
SCHEMBL3068648 0.70 P2RX3 (0.50)
SCHEMBL2259547 0.70 ADORA3 (0.56) SMN1; SMN2ADORA3KMT2AMEN1ADORA1
SCHEMBL17582100 0.70 RIPK1 (0.50) SMN1; SMN2TP53RIPK1KMT2AMEN1
SCHEMBL452633 0.70 RIPK1 (0.50) SMN1; SMN2TP53RIPK1KMT2AMEN1
SCHEMBL2259750 0.69 ADORA3 (0.56) SMN1; SMN2TP53ADORA3KMT2AMEN1
SCHEMBL1072108 0.68 P2RX3 (0.47) SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860178-A2 P2X3 receptor antagonists for treatment of pain Merck Sharp & Dohme Corp. (US) 2015-04-15 EP disclosed